/person/armstrong-frank-curagen-200603-corporation-nasdaq-crgn-group-2001-3657.html

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px
Person › Details

Frank M. Armstrong (CuraGen Corporation (Nasdaq: CRGN))

Armstrong, Frank M. (CuraGen 200603 CEO before Bioaccelerate before Provensis before Bayer before Zeneca)

 

     

   
Record changed: 2017-05-27

Advertisement

Picture [iito] – Putting Information into Context 600x102px


More documents for Frank M. Armstrong


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px




» top